NASDAQ · IVZ
Financial Services · Asset Management
$30.78
Down-$0.70 (-2.27%)
Updated Sep 17, 2026, 1:30 AM
SID Score
6.9/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 19 trading sessions · Daily adjusted prices
IVZ closed at $30.78 after 19 trading sessions, down 4.44% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $31.38 | $31.57 | $30.62 | $30.78 | 4.37M |
| Sep 14, 2026 | $31.72 | $31.94 | $31.11 | $31.51 | 3.54M |
| Sep 11, 2026 | $32.60 | $32.85 | $32.155 | $32.28 | 3.29M |
| Sep 10, 2026 | $31.94 | $32.42 | $31.6298 | $31.93 | 3.38M |
| Sep 9, 2026 | $32.39 | $32.56 | $32.08 | $32.09 | 3M |
| Sep 8, 2026 | $33.00 | $33.26 | $32.315 | $32.34 | 2.41M |
| Sep 4, 2026 | $32.32 | $33.335 | $32.30 | $33.07 | 2.86M |
| Sep 3, 2026 | $32.18 | $32.80 | $32.16 | $32.71 | 3.47M |
| Sep 2, 2026 | $31.99 | $32.715 | $31.65 | $31.72 | 3.02M |
| Sep 1, 2026 | $32.29 | $33.27 | $31.5658 | $31.99 | 4.82M |
| Aug 31, 2026 | $32.72 | $32.935 | $32.50 | $32.78 | 4.39M |
| Aug 28, 2026 | $33.41 | $33.66 | $32.64 | $32.86 | 2.78M |
| Aug 27, 2026 | $32.95 | $33.645 | $32.85 | $33.31 | 2.63M |
| Aug 26, 2026 | $32.73 | $33.31 | $32.37 | $32.98 | 3.62M |
| Aug 25, 2026 | $32.57 | $32.995 | $32.38 | $32.72 | 2.92M |
| Aug 24, 2026 | $32.07 | $32.635 | $31.90 | $32.45 | 2.8M |
| Aug 21, 2026 | $31.89 | $32.32 | $31.7201 | $32.02 | 3.09M |
| Aug 20, 2026 | $32.12 | $32.35 | $31.195 | $31.36 | 4.47M |
| Aug 19, 2026 | $32.80 | $32.80 | $32.075 | $32.21 | 3.27M |
The latest Smart Investors Daily articles mentioning IVZ.
IVZ research
Company profile and research snapshot.
Invesco provides investment-management services to retail (70% of managed assets) and institutional (30%) clients. At the end of September 2025, the firm had $2.125 trillion in assets under management spread among its equity (60% of AUM), balanced (3%), fixed-income (21%), alternative investment (6%), and money market (10%) operations. Passive products account for 47% of Invesco's total AUM. Invesco's US retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside of North America, with 31% of its AUM sourced from Europe, Africa, and the Middle East (16%) and Asia (15%).
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 9, 2026 | Evercore ISI Group | In-Line | — |
| Aug 13, 2026 | TD Cowen | Buy | — |
| Aug 10, 2026 | Evercore ISI Group | In-Line | — |
| Jul 29, 2026 | Barclays | Equal-Weight | — |
| Jul 29, 2026 | RBC Capital | Outperform | — |
No generated briefing is available yet.
Yahoo · Sep 11, 2026
Invesco’s 33.6% return over the past six months has outpaced the S&P 500 by 20.8%, and its stock price has climbed to $31.99 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Yahoo · Sep 11, 2026
PPH offers concentrated pharma exposure with 1.9% yield and lower volatility, while RSPH provides broader diversification across 60 healthcare holdings.
Yahoo · Sep 10, 2026
Invesco Ltd. (NYSE: IVZ)1, a leading global asset management firm announced today preliminary month-end assets under management (AUM) of $2,562.1 billion, an increase of 4.7% versus previous month-end. The firm delivered net long-term inflows of $27.6 billion in the month. Money market net inflows were $35.8 billion. AUM was positively impacted by favorable market returns which increased AUM by $49 billion. FX increased AUM by $2.7 billion. Preliminary average total AUM for the quarter through A
Yahoo · Sep 10, 2026
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning IVZ.
